EX-21.1 9 ibrx-20231231x10kexhibit211.htm EX-21.1
EXHIBIT 21.1
SUBSIDIARIES OF IMMUNITYBIO, INC.

Name of Subsidiary |  | Jurisdiction of Organization |  | Percentage of Voting Securities Owned Directly or Indirectly by ImmunityBio, Inc.
Infacell Therapeutics, Inc. |  | Delaware |  | 100.0%
Inex Bio, Inc. |  | Republic of Korea |  | 100.0%
NantCell, Inc. |  | Delaware |  | 100.0%
Etubics Corporation |  | Delaware |  | 100.0%
Altor BioScience, LLC |  | Delaware |  | 100.0%
Altor BioScience Manufacturing Company, LLC |  | Delaware |  | 100.0%
Receptome, Inc. |  | Delaware |  | 100.0%
VBC Holdings LLC |  | Delaware |  | 92.0%
VivaBioCell, S.p.A. |  | Italy |  | 100.0%
GlobeImmune, Inc. |  | Delaware |  | 69.1%
Immunotherapy NANTibody, LLC |  | Delaware |  | 100.0%
IgDraSol, Inc. |  | Delaware |  | 100.0%
MCLR Parent LLC |  | Delaware |  | 100.0%
Mariposa Clinic Co LLC |  | Delaware |  | 100.0%
Mariposa Lab Co LLC |  | Delaware |  | 100.0%
Mariposa Radiology Co LLC |  | Delaware |  | 100.0%
AccessBio LLC |  | Delaware |  | 50.0%

__________
Note: All of the subsidiaries shown above are included in our consolidated financial statements. Inactive subsidiaries have not been included in the above list.